Puhas Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 40.32%
(FY 2022)
- Ebitda 56.82%
(FY 2022)
- Net Worth -925.00%
(FY 2022)
- Total Assets 30.66%
(FY 2022)
About Puhas Lifesciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Makanbhai, Nisha Navle, and Bharti Kalawadia serve as directors at the Company.
- CIN/LLPIN
U24290GJ2019PTC108023
- Company No.
108023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2019
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Puhas Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Makanbhai  | Director | 07-May-2019 | Current |
| Nisha Navle | Director | 07-May-2019 | Current |
| Bharti Kalawadia | Director | 07-May-2019 | Current |
Financial Performance of Puhas Lifesciences.
Puhas Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 925%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Puhas Lifesciences?
Unlock access to Puhas Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cleargreens Pharmaceuticals Private LimitedActive 7 years 8 monthsRamesh Makanbhai and Nisha Navle are mutual person
Puhas Healthcare Private LimitedActive 5 years 1 monthRamesh Makanbhai and Nisha Navle are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Puhas Lifesciences?
Unlock and access historical data on people associated with Puhas Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Puhas Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puhas Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
